alexa Editor - Ahmed Lasfar | Cancer Center-University Hospital | 4503
ISSN: 2157-2526

Journal of Bioterrorism & Biodefense
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Ahmed Lasfar

Ahmed Lasfar Ahmed Lasfar
Department of Biochemistry and Molecular Biology
Cancer Center-University Hospital
UMDNJ-New Jersey Medical School
USA
Biography

Dr. Ahmed Lasfar is a Researcher, working on improving the use of Interferon in cancer and determining the mechanisms of resistance to interferon therapy, at the University Hospital Cancer Center, New Jersey Medical School/University of Medicine and Dentistry of New Jersey. He is a member of the Department of Biochemistry and Molecular Biology at NJMS/UMDNJ. He has completed his Post-Doctoral training (1999-2002) in the Department of Molecular Genetics, Microbiology and Immunology at Robert Wood Johnson Medical School, UMDNJ, under the supervision of Dr. Sidney Pestka (Leader for the approval of IFN use in Clinic, by the FDA in 1986 and the winner of the National Medal of Technology in 2002). Dr. Ahmed lasfar has received a PhD in Immunology from Paris University of Science, France in 1996. He has completed his Master Degree in Rene Descartes University, School of Medicine, France (1992). He received several awards, including two excellence scientific awards from the New Jersey Commission on Cancer Research and one award from the International Society for Interferon and Cytokine Research.

Research Interest

Interferon lambda signaling in normal and cancer cells, Strategies for the improvement of interferon treatment in melanoma, Role of Interferon lambdas in Hepatocelluar Carcinoma, Mechanisms of TGF beta resistance, Interaction between TGF beta and Interferons.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version